For US Healthcare Professionals Only
Filter
Real-World Use of Fenfluramine for Dravet Syndrome: A Retrospective Cohort Study Using a National Pharmacy Database
Post-Hoc Analysis of Fenfluramine for Lennox-Gastaut Syndrome by Baseline Frequency Quartiles of Seizures Associated With a Fall
Onset and Duration of Adverse Events in Patients Treated With Fenfluramine in the Lennox-Gastaut Syndrome Clinical Trials
Preliminary baseline results from the CANDID study: An observational study in patients with CDKL5 Deficiency Disorder
Automated Assessment of Sleep in Patients With Dravet Syndrome From Simulated Behind-the-Ear EEG
HEADFIRST: Preliminary Results From Home Sleep EEG Testing in Patients With LGS
Sleep Apnea is Associated With High Mortality Risk in Children With Severe Epilepsies: An Observational Analysis From Large Scale US Claims Data
Interim Results of the US Fenfluramine Oral Solution Cardiovascular Safety Registry Study
Disruptive Impacts of Developmental and Epileptic Encephalopathies on Patient and Family Life: A Quality-of-Life Survey
Fenfluramine Safety: An Update From Post-Marketing Reports
Fenfluramine Efficacy Trajectories in Placebo or Treatment Groups From Randomized Controlled Trial to Open-Label Extension
A Stratified Analysis of Efficacy and Safety of Fenfluramine in Patients With Dravet Syndrome
Comprehensive Analysis of Lennox-Gastaut Syndrome in Europe: Treatment Patterns, Healthcare Utilisation, and Quality of Life
Antiseizure Medication Regimen Adjustment After Fenfluramine Initiation: Lessons Learned From European Early Access Program in Pediatric and Adult Patients With Dravet Syndrome
A Post-Hoc Evaluation of Fenfluramine With or Without Vagus Nerve Stimulation in Lennox-Gastaut Syndrome Clinical Trials
Inhalation as an Efficient Delivery Route of Alprazolam for the Treatment of Acute Seizures: Randomized Study of Staccato®Alprazolam Relative to Oral Alprazolam
Impact of Prolonged Seizures on Patients’ and Caregivers’ Quality of Life
What Are the Experiences of Women of Childbearing Age With Epilepsy Throughout Their Motherhood Journey? Results From a Social Media Listening Study
Effectiveness and Tolerability of Adjunctive Brivaracetam in Adults With Focal-Onset Seizures on One Specific Antiseizure Medication: Post Hoc Analysis of Interim Real‐World Data From BRITOBA
Patient-Reported Outcomes in Adults With Focal-Onset Seizures Who Completed 12 Months of Adjunctive Brivaracetam in Earlier Treatment Lines: Post Hoc Analysis of Interim Real-World Data From BRITOBA
Tolerability and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients With Focal-Onset Seizures: Interim and Post Hoc Analysis of a Phase 3, Open-Label Extension Trial
Time Course of Treatment-Emergent Adverse Events in Adult Asian Patients With Focal-Onset Seizures During Adjunctive Brivaracetam Treatment: A Post Hoc Analysis of a Phase III, Randomized Trial
Long-Term Tolerability and Efficacy of Adjunctive Brivaracetam in Pediatric Patients With Primary Generalized Seizures: Subgroup Analysis of an Open-Label, Follow-Up Trial
Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization Among Patients With Epilepsy on Brivaracetam Monotherapy: A Cohort Study Using US Claims Data